Laura Kupsch

Laura Kupsch, DRSc has a long history of work experience in the field of quality assurance. Laura began their career in 1998 as President of GCP Advisors. Laura then moved to Eyetech Pharmaceuticals in 2003 as Director, Regulatory Compliance, followed by a role as Director, Clinical QA the following year. In 2005, they became Director, Regulatory and Compliance at Pharmasset, Inc. Laura then moved to Otsuka Pharmaceutical Companies (U.S.) in 2013 as Director, Quality Control, followed by a role as Sr. Director Quality Assurance at Ophthotech Corp. the same year. In 2017, they were appointed Executive Director, Head of Quality at Nutrinia. Laura then moved to Melinta Therapeutics in 2018 as Vice President, GxP Quality. In 2019, they took on the same role at Passage Bio, and in 2022 they will become Vice President Quality Assurance at EyeBio.

Laura Kupsch, DRSc is currently a Regulatory Science Candidate at the University of Southern California, where they are expected to complete their Doctor of Regulatory Science degree in 2022. Prior to this, they completed their Master's degree at Temple University. Before their post-graduate studies, they attended Marist College and Hillsborough High School.